Indivior Pharmaceuticals, Inc. - Common Stock (NQ:INDV)

36.28 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Indivior Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Here's Why Indivior Stock Soared 15% Today ↗

October 30, 2025

This company is accelerating sales growth in its key prescription medication.

Via The Motley Fool

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

INDIVIOR PLC (NASDAQ:INDV) Shows Top Technical and Setup Ratings for Potential Breakout ↗

October 20, 2025

INDIVIOR (INDV) shows strong technicals with a perfect 10 rating and a 9 setup score, signaling a potential breakout above $25.20 resistance.

Via Chartmill

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

August 06, 2025

Via Benzinga

Indivior (INDV) Q2 EPS Jumps 104% ↗

August 01, 2025

Via The Motley Fool

Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For April 24, 2025 ↗

April 24, 2025

Via Benzinga

Indivior (INDV) Q1 2025 Earnings Call ↗

April 24, 2025

Via The Motley Fool

A Look at Indivior's Upcoming Earnings Report ↗

April 23, 2025

Via Benzinga

Indivior PLC: Is This Deeply Undervalued Stock A Hidden Gem? ↗

April 13, 2025

With a strong position in a niche yet vital therapeutic area, Indivior PLC benefits from durable brand equity, a specialized distribution network, and a long runway for product innovation.

Via Talk Markets

Topics Stocks / Equities

European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat ↗

February 20, 2025

Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 20, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 11, 2024

Via Benzinga

S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results ↗

October 10, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 10, 2024

Via Benzinga

Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings ↗

October 10, 2024

Via Benzinga

Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details ↗

October 10, 2024

Indivior cuts FY24 net revenue outlook due to competition and funding delays, causing a drop in share price.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 10, 2024

Via Benzinga

INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm

October 01, 2024

From The Schall Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV)

September 30, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

INDV Deadline: Rosen Law Firm Urges Indivior PLC (INDV) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

September 29, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm

September 25, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Indivior PLC Investors to Secure Counsel Before Important October 1 Deadline in Securities Class Action – INDV

September 23, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Top 3 Health Care Stocks That May Explode This Month ↗

September 23, 2024

Via Benzinga

INDIVIOR PLC (NASDAQ: INDV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline

September 23, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm

September 21, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Indivior PLC REMINDER – INDV Stockholders Should Contact Robbins LLP for Information About the Indivior PLC Class Action and Pending Lead Plaintiff Deadline

September 18, 2024

From Robbins LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, CrowdStrike, DXC, and Five Below and Encourages Investors to Contact the Firm

September 17, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.